We work closely with and support the leading international pharmaceutical companies, large Polish players, as well as financial investors on their M&A projects aimed at establishing the market presence in the Polish pharmaceutical market, adding the scale to their existing operations or expanding into new adjacent sectors or categories.

• Enter Polish pharma market

• Acquire brands or products

• Acquire business units / competences

•  Sell a company or a part of shares in a company

•  Find an investor who would bring in fresh capital, products and/or know-how

• Sell a brand or portfolio of products

• Sell non-core operations

We understand well that selling the business is often the largest project in an entrepreneur’s career. We help the owners of pharmaceutical companies in the identification of the most  attractive buyers for their businesses, managing the whole divestment process incl. the negotiations of terms of such transactions.

We offer advisory services to the business owners or general managers who decide to streamline the existing operations and divest some non-core parts of their  business, e.g. individual brands or business units and use the proceeds for funding the expansion of the core operations.